Novartis Pharmaceuticals Corporation

Profile

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives. Our medicines reach more than 250 million people worldwide. In cardiovascular disease, Entresto (sacubitril/valsartan) is the only neprilysin inhibitor for use in heart failure patients, and Leqvio (incliseran) is the first-in-class small-interfering RNA medication targeting the PCSK9 protein, thus lowering LDL cholesterol.

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives. Our medicines reach more than 250 million people worldwide. In cardiovascular disease, Entresto (sacubitril/valsartan) is the only neprilysin inhibitor for use in heart failure patients, and Leqvio (incliseran) is the first-in-class small-interfering RNA medication targeting the PCSK9 protein, thus lowering LDL cholesterol.